跳至主要内容
临床试验/NCT07607132
NCT07607132已完成不适用

Digitally Delivered Dietary Treament for Irritable Bowel Syndrome

Sahlgrenska University Hospital1 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2024年5月2日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
32
试验地点
1

研究概览

简要总结

Two carbohydrate reduced diets, the low FODMAP diet (LFD) and low-carbohydrate diet (LCD), have in randomized controlled studies shown efficacy in relieving symptoms in patients with Irritable Bowel Syndrome (IBS), but access to trained dieticians is limited. Digital delivery may offer a convenient, cost-effective and scalable solution. This pilot study aims to evaluate the effectiveness and feasibility of digitally delivered evidence-based dietary treatments in relieving gastrointestinal, psychological and somatic symptoms and improving quality of life in patients with IBS.

Adults with IBS will be recruited via social media and clinical referrals and will receive their choice of the two dietary treatments: LFD with traditional IBS dietary advice or LCD. Participants will get access to the digital platform which contains information about the study, IBS pathophysiology, the treatment diet along with recipes and a mobile application for food scanning. Participants will complete digital questionnaires at baseline and week four to evaluate changes in gastrointestinal symptoms (IBS-SSS), somatic and psychological symptoms (PHQ-15, HADS, VSI) and quality of life (IBS-QoL). Feasibility and adherence is assessed with an evaluation questionnaire.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 64 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosed with IBS (Rome IV) by physician
  • Age 18-64
  • Ability to read and understand Swedish
  • Signed informed consent

排除标准

  • Received dietary treatmen for IBS previously
  • Manifestations of other conditions that may explain gastrointestinal symptoms
  • Manifestation of other serious medical conditions
  • Patients with ongoing eating disorders
  • Pregnant/lactating women

研究者

发起方
Sahlgrenska University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Magnus Simrén

Professor

Göteborg University

研究点 (1)

Loading locations...

相似试验